Results for Animal

1 - 10 of 294

Dr. Smith is a laboratory animal medicine veterinarian. As Technical Director of the CCMT Comparative Medicine Services Core, he helps guide promising therapeutics and devices from discovery and developmental studies through nonclinical studies.

E-mail:

smithgr [at] chop.edu

Patrick J. Cahill, MD

Dr. Cahill's focuses on improving treatments for patients with early onset chest and spinal deformity, employing a combination of clinical, biomechanical, and basic science research approaches.

E-mail:

cahillp1 [at] chop.edu

Seema Bhatnagar, PhD

Dr. Bhatnagar's research aims to further the understanding of the neural basis of individual differences in response to stressful experiences. This includes identifying neural substrates that produce resiliency or vulnerability to the effects of stress and determining treatments to mitigate vulnerability and to promote resiliency through both preclinical and translational studies.

E-mail:

bhatnagars [at] chop.edu

Cindy W. Christian, MD

E-mail:

christian [at] chop.edu

Kristy L. Weber, MD, FACS

E-mail:

weberk [at] chop.edu

Robert Sutton MD, MSCE, FAAP, FCCM

Dr. Sutton is an internationally recognized expert in pediatric cardiac arrest. His career focus is on developing and evaluating novel techniques and devices to improve the care delivered during in-hospital resuscitation attempts.

E-mail:

suttonr [at] chop.edu

Andrei Thomas-Tikhonenko, PhD

Dr. Thomas-Tikhonenko has a long-standing interest in the pathobiology of solid and hematopoietic malignancies, in particular lymphomas and leukemias and other cancers driven by MYC overexpression. Within that research space, his studies focus mainly (but not exclusively) on RNA-based regulatory mechanisms, such as microRNAs and alternative mRNA splicing.

E-mail:

thomastikhonenko [at] chop.edu

Evelyn K. Shih, MD, PhD

Dr. Shih studies the metabolic interplay between cell types within the neurovascular unit during stroke to develop effective, novel mitochondrial-directed therapeutics to improve post-stroke disability. She works with small and large animal models of childhood arterial ischemic stroke.

E-mail:

shihe [at] chop.edu

Beverly L. Davidson, PhD

Dr. Davidson works to understand the molecular basis of childhood onset neurodegenerative diseases and the development of gene and small molecule therapies for treatment. She also focuses on how noncoding RNAs participate in neural development and neurodegenerative disease processes, and how they can be harnessed for therapies.

E-mail:

davidsonbl [at] chop.edu

Paris Margaritis, DPhil

Dr. Margaritis uses biochemical, molecular, and complex in vivo methodology within the field of coagulation to advance the understanding of molecular mechanisms involved in pro- and anti-coagulant reactions, and translate research for the treatment of coagulation defects.

E-mail:

margaritis [at] chop.edu